EFSA's February 2026 re-evaluation kept sucralose's ADI at 15 mg/kg, found no genotoxicity concern, and would not confirm safety for high-heat fine bakery use.
9/10/2026 · 7 min read · Chris Carrillo · Reviewed by Armin Rad, Co-Founder & CTO, Aurascan · Last reviewed 9/10/2026
Editorial accountability
Written by Chris Carrillo. Reviewed by Armin Rad, Co-Founder & CTO, Aurascan. It cites 4 sources; use the source list and methodology to check the evidence directly.
Walk through a crawlable sample result, including what comes from the label, what needs evidence, and what the scanner cannot conclude.
View the sample resultPARMA, Italy. In February 2026, the European Food Safety Authority concluded its systematic re-evaluation of sucralose (E955), confirming existing food uses are safe and maintaining its Acceptable Daily Intake of 15 mg/kg body weight per day while rejecting an extension for high-temperature commercial baking due to thermal breakdown products.
In February 2026, the European Food Safety Authority Panel on Food Additives and Flavourings published its comprehensive Scientific Opinion on the safety of sucralose (E955). The assessment was conducted under the European Union's systematic re-evaluation program for all food additives authorized before January 20, 2009. The agency reviewed hundreds of toxicological, exposure, and metabolic studies submitted by manufacturers and independent researchers over the preceding decade, documenting its conclusions in the EFSA sucralose re-evaluation opinion.
The expert panel concluded that the current Acceptable Daily Intake (ADI) of 15 mg/kg body weight per day remains toxicologically protective for all general population groups, including children and pregnant individuals. Alongside this baseline re-evaluation, the panel assessed an industry application seeking to permit sucralose in industrial fine bakery wares. As detailed in the EFSA news announcement, EFSA explicitly refused to confirm the safety of this proposed use extension, citing insufficient evidence regarding thermal degradation products produced under prolonged baking conditions.
Across the Atlantic, the US Food and Drug Administration (FDA) has maintained its existing standard. As of September 10, 2026, the FDA continues to apply an ADI of 5 mg/kg body weight per day for sucralose, which it approved for limited uses in 1998 and as a general-purpose sweetener in 1999. Federal authorities continue to coordinate with global toxicologists to monitor real-world dietary exposure data across processed foods.
The primary scientific conclusion of the 2026 EFSA opinion is the formal clearance of genotoxic and carcinogenic suspicions that had emerged in public debates. EFSA evaluated recent bioassays and published toxicology data, concluding that pure sucralose and its manufacturing impurities (including sucralose-6-acetate) do not demonstrate genotoxic potential in vivo at real-world consumer concentrations.
What changed practically is the boundary of regulatory approval for food processors. While existing authorizations for soft drinks, dairy desserts, confectionery, table-top sweeteners, and sauces remain active, the European Commission will not expand permitted categories to include mass-manufactured baked goods like industrial cakes, cookies, and pastries. The panel could not rule out that prolonged high-temperature baking breaks sucralose down into chlorinated compounds, including chloropropanols such as 3-MCPD, which carry known toxicological concerns, and the applicant's data did not resolve that question.
In the United States, ongoing debates surrounding food ingredient oversight remain active. Consumers tracking regulatory shifts can review Which Food Additives Are Banned in Which US State (2026 Tracker) to see how state-level legislatures handle additive reviews alongside federal agencies. Similarly, the federal landscape continues to evolve as the FDA Proposes Ending Self-Affirmed GRAS: What Changes for You aims to tighten oversight on emerging food ingredients.
This regulatory outcome directly affects packaged food manufacturers, beverage formulators, and everyday shoppers who consume zero-calorie or reduced-sugar items. Because existing approvals remain intact, formulations for diet sodas, protein powders, flavored waters, and zero-calorie syrups do not require reformulation or label changes.
Industrial baking manufacturers who hoped to use sucralose as a direct thermal replacement for sugar in European packaged goods cannot proceed under current EU rules. However, home consumers who bake with sucralose tabletop blends remain unregulated by this decision, though the underlying thermal chemistry remains relevant to home cooking.
Individuals managing specific health conditions are affected in distinct ways:
Dietary habits are also shifting as beverage brands reformulate products, similar to trends seen where Food Brands Race to Drop Artificial Dyes Before 2027 and explore cleaner ingredient profiles.
For consumers reading ingredient lists at the grocery store, the EFSA conclusion confirms that existing products containing sucralose meet current international safety standards. On food labels, sucralose is identified plainly by name in the United States and as either "sucralose" or "E955" across the European Union and the United Kingdom.
Shoppers looking to evaluate their own intake can reference the standard Acceptable Daily Intake values:
If you use sucralose-based tabletop sweeteners for cooking, EFSA's findings suggest caution when subjecting the sweetener to sustained, high-temperature dry baking. For light cooking, cold preparation, or sweetening hot beverages like coffee and tea, thermal degradation is negligible because temperatures do not reach the threshold required for significant chemical breakdown.
Understanding how regulatory agencies re-evaluate historical additives provides helpful context across the supermarket aisles. For example, federal oversight mechanisms are also evolving in other categories, as detailed in our guide on how the FDA Opens Formal Safety Reassessment of BHT: What It Means. In addition, broader market changes like The Natural Food Colors the FDA Approved to Replace Dyes demonstrate the ongoing shift in additive safety reviews.
Sucralose is an organochlorine sweetener synthesized by selectively replacing three hydroxyl groups on a sucrose molecule with chlorine atoms. This chemical structure prevents digestive enzymes from breaking it down for energy.
The February 2026 decision marks a key milestone in EFSA's systematic re-evaluation of all intense sweeteners. Over the past decade, European authorities have methodically reviewed the safety data for authorized sweeteners under Regulation (EC) No 257/2010:
Throughout the late 2010s and early 2020s, academic publications raised questions regarding potential DNA reactivity from sucralose manufacturing intermediates, alongside clinical trials on short-term impact of sucralose consumption on the metabolic response. EFSA's 2026 review represents the culmination of assessing these newer studies against standardized toxicological benchmarks.
Other specialty food categories have faced similar historical evaluations, including regional restrictions like Potassium Bromate Bans: What States Have Done and When, international guidance such as Glycerol in Slush Drinks: EFSA Sets a Limit, UK Says No Under 7, and disclosure rules outlined in Baby Food Heavy-Metal Test Results Are Now on the Label.
Following EFSA's February 2026 scientific opinion, the European Commission and member state representatives will formalize the administrative rejection of the fine bakery wares application in the EU Standing Committee on Plants, Animals, Food and Feed (PAFF Committee).
Meanwhile, international toxicological researchers continue to explore remaining scientific questions. Independent research continues on the gut microbiome, long-term metabolic interactions during carbohydrate co-ingestion, and secondary metabolites. What current evidence cannot establish with absolute certainty is whether individual, idiosyncratic digestive reactions occur in individuals with pre-existing inflammatory bowel disorders, as broad toxicological safety assessments evaluate general population risk rather than personal tolerance.
For shoppers seeking clarity when navigating packaged food claims, checking labels directly remains the best approach. When you want instant clarity on sweeteners, additives, and preservatives in your groceries, you can easily check your products using Aurascan.
No. In February 2026, EFSA concluded that sucralose is safe at current authorized levels and maintained its Acceptable Daily Intake (ADI) of 15 mg/kg body weight per day. It only declined to approve an expanded use in commercial high-temperature baking.
The US FDA maintains an Acceptable Daily Intake (ADI) of 5 mg/kg body weight per day, while the European Food Safety Authority (EFSA) sets the limit at 15 mg/kg body weight per day. Both agencies consider currently authorized food uses fully safe.
EFSA found that subjecting sucralose to prolonged high-temperature industrial baking can generate chlorinated degradation products, including chloropropanols, creating safety uncertainties for mass-manufactured baked goods.
No. EFSA evaluated recent modern bioassays and concluded that neither pure sucralose nor its known impurities cause genotoxicity or DNA damage at real-world consumer exposure levels.
In the United States, it is listed as 'sucralose' on the ingredient statement. In the European Union and the UK, it appears either as 'sucralose' or by its additive code 'E955'.
Aurascan turns product labels into plain-English ingredient explanations and source-backed context.
Scan your next label with AurascanWhat changed on food labels this week — bans, recalls, and new guides.
Source labels distinguish peer-reviewed research, regulatory material, and Aurascan label data when that classification is available.
A 17,710-person cohort study presented at ESC Congress 2026 links high blood xylitol to more heart events. What it shows, what it cannot, and what to do.
Galdieria blue, butterfly pea flower extract, calcium phosphate and gardenia blue: what the FDA approved in 2025, where each can be used, and what changes on labels.
The FDA launched a post-market reassessment of azodicarbonamide (ADA) on May 12, 2026. What ADA is, why the EU bans it, and how to spot it on bread labels.
